Literature DB >> 26947759

Behavioral Analysis of Dopaminergic Activation in Zebrafish and Rats Reveals Similar Phenotypes.

Fredrik Ek, Marcus Malo, Madelene Åberg Andersson, Christoffer Wedding, Joel Kronborg, Peder Svensson1, Susanna Waters1, Per Petersson, Roger Olsson.   

Abstract

Zebrafish is emerging as a complement to mammals in behavioral studies; however, there is a lack of comparative studies with rodents and humans to establish the zebrafish as a predictive translational model. Here we present a detailed phenotype evaluation of zebrafish larvae, measuring 300-3000 variables and analyzing them using multivariate analysis to identify the most important ones for further evaluations. The dopamine agonist apomorphine has previously been shown to have a complex U-shaped dose-response relationship in the variable distance traveled. In this study, we focused on breaking down distance traveled into more detailed behavioral phenotypes for both zebrafish and rats and identified in the multivariate analysis low and high dose phenotypes with characteristic behavioral features. Further analysis of single parameters also identified an increased activity at the lowest concentration indicative of a U-shaped dose-response. Apomorphine increased the distance of each swim movement (bout) at both high and low doses, but the underlying behavior of this increase is different; at high dose, both bout duration and frequency increased whereas bout max speed was higher at low dose. Larvae also displayed differences in place preference. The low dose phenotype spent more time in the center, indicative of an anxiolytic effect, while the high-dose phenotype had a wall preference. These dose-dependent effects corroborated findings in a parallel rat study and previous observations in humans. The translational value of pharmacological zebrafish studies was further evaluated by comparing the amino acid sequence of the dopamine receptors (D1-D4), between zebrafish, rats and humans. Humans and zebrafish share 100% of the amino acids in the binding site for D1 and D3 whereas D2 and D4 receptors share 85-95%. Molecular modeling of dopamine D2 and D4 receptors indicated that nonconserved amino acids have limited influence on important ligand-receptor interactions.

Entities:  

Keywords:  Zebrafish; apomorphine; behavioral model; dopamine agonist; receptor binding site

Mesh:

Substances:

Year:  2016        PMID: 26947759     DOI: 10.1021/acschemneuro.6b00014

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  14 in total

Review 1.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

2.  A microfluidic device to study electrotaxis and dopaminergic system of zebrafish larvae.

Authors:  Amir Reza Peimani; Georg Zoidl; Pouya Rezai
Journal:  Biomicrofluidics       Date:  2018-02-07       Impact factor: 2.800

3.  Detection and Prioritization of Developmentally Neurotoxic and/or Neurotoxic Compounds Using Zebrafish.

Authors:  Celia Quevedo; Mamta Behl; Kristen Ryan; Richard S Paules; Aintzane Alday; Arantza Muriana; Ainhoa Alzualde
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

Review 4.  Zebrafish Larvae Behavior Models as a Tool for Drug Screenings and Pre-Clinical Trials: A Review.

Authors:  João Gabriel Santos Rosa; Carla Lima; Monica Lopes-Ferreira
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

5.  High PGD2 receptor 2 levels are associated with poor prognosis in colorectal cancer patients and induce VEGF expression in colon cancer cells and migration in a zebrafish xenograft model.

Authors:  Pujarini Dash; Souvik Ghatak; Geriolda Topi; Shakti Ranjan Satapathy; Fredrik Ek; Karin Hellman; Roger Olsson; Lubna M Mehdawi; Anita Sjölander
Journal:  Br J Cancer       Date:  2021-11-08       Impact factor: 9.075

6.  Action sequencing in the spontaneous swimming behavior of zebrafish larvae - implications for drug development.

Authors:  Tobias Palmér; Fredrik Ek; Olof Enqvist; Roger Olsson; Kalle Åström; Per Petersson
Journal:  Sci Rep       Date:  2017-06-09       Impact factor: 4.379

7.  Pharmacological analysis of zebrafish lphn3.1 morphant larvae suggests that saturated dopaminergic signaling could underlie the ADHD-like locomotor hyperactivity.

Authors:  Merlin Lange; Cynthia Froc; Hannah Grunwald; William H J Norton; Laure Bally-Cuif
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-02-26       Impact factor: 5.067

8.  Effects of tenuifolin on rest/wake behaviour in zebrafish.

Authors:  Zi-Wen Chen; Chao-Bao Peng; Zhong Pei; Meng-Ruo Zhang; Tian-Chan Yun; Zhi-Min Yang; Fu-Ping Xu
Journal:  Exp Ther Med       Date:  2020-01-28       Impact factor: 2.447

9.  Zebrafish studies identify serotonin receptors mediating antiepileptic activity in Dravet syndrome.

Authors:  Aliesha L Griffin; Priyadarshini Jaishankar; Jean-Marc Grandjean; Steven H Olson; Adam R Renslo; Scott C Baraban
Journal:  Brain Commun       Date:  2019-08-01

10.  Visuomotor deficiency in panx1a knockout zebrafish is linked to dopaminergic signaling.

Authors:  Nickie Safarian; Paige Whyte-Fagundes; Christiane Zoidl; Jörg Grigull; Georg Zoidl
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.